Registration Dossier

Administrative data

Link to relevant study record(s)

Description of key information

FAT 45176/A is expected to be absorbed in human via different routes - oral (assumed 30%), dermal (assumed 10%) and inhalation route (assumed 85%) due  to  the  physico-chemical  properties  (i.e.,  high  molecular  weight,  highly water  solubility,  main  particle  size  is  smaller  than  100  µm,  low  Log  Pow). 
Following absorption, FAT 45176/A is anticipated to be distributed at the very least to liver and kidneys. Excretion is expected to be fast in its original form via urine bile or feces, and as a conclusion FAT 45176/A has low accumulation potential in human body.

Key value for chemical safety assessment

Bioaccumulation potential:
low bioaccumulation potential
Absorption rate - oral (%):
30
Absorption rate - dermal (%):
10
Absorption rate - inhalation (%):
85

Additional information